Somaxon Sues Actavis Over Generic Silenor
By Megan Leonhardt ( May 10, 2011, 7:22 PM EDT) -- Somaxon Pharmaceuticals Inc. hit Actavis Inc. with a patent infringement suit in Delaware on Monday over Actavis' bid for regulatory approval to market a generic version of Somaxon's insomnia drug Silenor....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.